Skip to main content
. 1998 Apr;112(1):112–119. doi: 10.1046/j.1365-2249.1998.00537.x

Fig. 4.

Fig. 4

Sirolimus (SRL) and FK506 inhibit both αβ and γδ T lymphocytes. Four day trinitrochlorobenzene (TNCB)-immune lymph node cells from mice that had been treated with SRL or FK506 were transferred into naive recipient mice together with combinations of two positively selected populations of αβ+, γδ+ or B220+ T lymphocytes. *P < 0.001 compared with the negative control group.